iShares Genomics Immunology and Healthcare ETF Rating $20.49 -0.51 (-2.43%) Closing price 04:10 PM EasternExtended Trading$20.50 +0.01 (+0.02%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy 2.75Holdings in IDNA have an aggregate rating of Moderate Buy based on 424 analyst ratings issued in the past year covering 39 companies (61.0% of the portfolio).IDNA Aggregate Price Target$20.49High Prediction$20.49Average Prediction$20.49Low Prediction$20.49Holdings in IDNA have an aggregate price target of $20.49 and a range of $20.49 to $20.49 covering 39 companies (61.0% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 39 IDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.15%SWTXSpringWorks Therapeutics$44.13-6.9%2.3531 of 5 stars3.00$73.20 65.9%5Positive NewsGap Down4.78%EXELExelixis$36.92+0.6%4.5343 of 5 stars2.50$37.59 1.8%20Upcoming EarningsAnalyst RevisionPositive News4.23%MRKMerck & Co., Inc.$89.74+0.6%5 of 5 stars2.65$117.12 30.5%233.92%REGNRegeneron Pharmaceuticals$634.23-0.5%4.8189 of 5 stars2.76$966.88 52.4%25Analyst ForecastShort Interest ↑Positive News3.89%ACLXArcellx$65.60-3.5%2.2629 of 5 stars3.13$108.46 65.3%15Positive NewsGap Down3.69%RVMDRevolution Medicines$35.36-5.3%4.2435 of 5 stars3.08$66.31 87.5%13News CoveragePositive NewsGap Down3.68%INCYIncyte$60.55-0.1%4.8974 of 5 stars2.21$74.88 23.7%193.64%BNTXBioNTech$91.06-4.1%2.8497 of 5 stars2.89$143.73 57.8%18Gap DownHigh Trading Volume3.62%TWSTTwist Bioscience$39.26-2.7%3.9888 of 5 stars2.70$54.40 38.6%10Gap Down3.36%MRNAModerna$28.35-8.9%4.1879 of 5 stars2.04$59.00 108.1%24News CoverageGap DownHigh Trading Volume2.22%BCRXBioCryst Pharmaceuticals$7.50-4.6%4.3037 of 5 stars2.86$15.57 107.6%7Short Interest ↑Positive News2.16%JANXJanux Therapeutics$27.00-7.2%2.5956 of 5 stars3.08$92.44 242.4%12Gap Down1.81%NVAXNovavax$6.41-8.4%3.9613 of 5 stars2.43$18.00 180.8%7News CoveragePositive NewsGap Down1.51%GERNGeron$1.59-3.6%4.3571 of 5 stars2.82$5.75 261.6%11Short Interest ↓1.36%XNCRXencor$10.64-5.3%3.7022 of 5 stars3.13$34.38 223.1%8Gap Down1.34%IOVAIovance Biotherapeutics$3.33-6.5%4.2648 of 5 stars2.88$20.25 508.1%8Gap Down0.92%VIRVir Biotechnology$6.48-3.3%3.8275 of 5 stars2.83$35.67 450.4%6News CoveragePositive NewsGap Down0.81%ABCLAbCellera Biologics$2.23-3.5%2.2299 of 5 stars2.67$7.00 213.9%3Positive NewsGap Down0.78%KURAKura Oncology$6.60-6.4%4.2669 of 5 stars2.92$25.50 286.4%12Gap Down0.67%RCUSArcus Biosciences$7.87-3.7%2.2052 of 5 stars3.00$30.25 284.6%100.67%IMNMImmunome$6.73-3.7%2.1054 of 5 stars3.00$25.50 278.9%6Positive NewsGap DownHigh Trading Volume0.67%IBRXImmunityBio$3.01-4.1%2.0089 of 5 stars3.00$12.19 304.9%5Analyst Forecast0.54%MREOMereo BioPharma Group$2.25-2.2%2.3867 of 5 stars3.25$7.71 242.9%8Earnings ReportAnalyst Revision0.54%RIGLRigel Pharmaceuticals$17.99+0.6%2.9259 of 5 stars2.40$36.80 104.6%5Positive NewsGap DownHigh Trading Volume0.53%VERVVerve Therapeutics$4.57-12.5%1.7844 of 5 stars3.00$25.50 458.0%6Gap Down0.49%CELCCelcuity$10.11-1.3%1.5865 of 5 stars3.14$30.17 198.4%7News Coverage0.48%ARCTArcturus Therapeutics$10.59-8.5%3.0275 of 5 stars3.13$59.20 459.0%8Positive NewsGap Down0.48%ORICORIC Pharmaceuticals$5.58-9.1%4.0921 of 5 stars3.00$18.86 237.9%9Gap DownHigh Trading Volume0.47%PACBPacific Biosciences of California$1.18+3.5%2.4724 of 5 stars2.54$2.46 108.3%13Short Interest ↓Gap Down0.40%DNAGinkgo Bioworks$5.71-6.8%0.5139 of 5 stars1.60$4.58 -19.8%5Gap Down0.36%ALLOAllogene Therapeutics$1.46-5.8%3.0024 of 5 stars2.90$9.29 536.2%10Gap Up0.34%CRSPCRISPR Therapeutics$34.03-8.0%3.3921 of 5 stars2.48$73.11 114.8%21Gap DownHigh Trading Volume0.34%OABIOmniAb$2.40-0.8%2.9493 of 5 stars3.00$7.00 191.7%3Gap Down0.26%SGMOSangamo Therapeutics$0.66-19.5%2.6903 of 5 stars2.67$5.17 682.8%6Positive NewsGap Down0.22%FDMT4D Molecular Therapeutics$3.23-11.0%2.6498 of 5 stars2.60$30.63 848.1%10Gap Down0.21%LGNDLigand Pharmaceuticals$105.14-2.3%4.4733 of 5 stars3.00$147.00 39.8%6Short Interest ↑Positive News0.21%CRGXCARGO Therapeutics$4.07-2.6%3.1291 of 5 stars1.86$15.00 268.6%7Positive News0.17%BEAMBeam Therapeutics$19.53-12.1%3.1991 of 5 stars3.00$49.45 153.2%14Analyst UpgradeShort Interest ↑Gap DownHigh Trading Volume0.09%NTLAIntellia Therapeutics$7.11-11.9%4.4437 of 5 stars2.63$37.56 428.2%19Analyst RevisionGap DownHigh Trading Volume This page (NYSEARCA:IDNA) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
